Premium
Prohibitins Role in Cellular Survival Through Ras‐Raf‐MEK‐ERK Pathway
Author(s) -
Chowdhury Indrajit,
Thompson Winston E.,
Thomas Kelwyn
Publication year - 2014
Publication title -
journal of cellular physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 174
eISSN - 1097-4652
pISSN - 0021-9541
DOI - 10.1002/jcp.24531
Subject(s) - mapk/erk pathway , microbiology and biotechnology , chemistry , biology , cancer research , kinase
Prohibitins are members of a highly conserved protein family containing the stomatin/prohibitin/flotillin/HflK/C (SPFH) domain (also known as the prohibitin [PHB] domain) found in unicellular eukaryotes, fungi, plants, animals, and humans. Two highly homologous members of prohibitins expressed in eukaryotes are prohibitin (PHB; B‐cell receptor associated protein‐32, BAP‐32) and prohibitin 2/repressor of estrogen receptor activity (PHB2, REA, BAP‐37). Both PHB and REA/PHB2 are ubiquitously expressed and are present in multiple cellular compartments including the mitochondria, nucleus, and the plasma membrane. Multiple functions have been attributed to the mitochondrial and nuclear PHB and PHB2/REA including cellular differentiation, anti‐proliferation, and morphogenesis. One of the major functions of the prohibitins are in maintaining the functional integrity of the mitochondria and protecting cells from various stresses. In the present review, we focus on the recent research developments indicating that PHB and PHB2/REA are involved in maintaining cellular survival through the Ras‐Raf‐MEK‐Erk pathway. Understanding the molecular mechanisms by which the intracellular signaling pathways utilize prohibitins in governing cellular survival is likely to result in development of therapeutic strategies to overcome various human pathological disorders such as diabetes, obesity, neurological diseases, inflammatory bowel disease, and cancer. J. Cell. Physiol. 229: 998–1004, 2014. © 2013 Wiley Periodicals, Inc.